Tenecteplase
Showing 1 - 25 of 110
Acute Ischemic Stroke Trial (Tenecteplase plus Tirofiban, Tenecteplase plus Placebo)
Not yet recruiting
- Acute Ischemic Stroke
- Tenecteplase plus Tirofiban
- Tenecteplase plus Placebo
- (no location specified)
Nov 2, 2022
Stroke, Ischemic Trial in Shenyang (Tenecteplase)
Not yet recruiting
- Stroke, Ischemic
- Tenecteplase
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Aug 23, 2023
Ischemic Stroke, Acute Trial (Shuxuetong Injection)
Not yet recruiting
- Ischemic Stroke, Acute
- Shuxuetong Injection
- (no location specified)
Aug 24, 2023
Early Recanalization After Intravenous Thrombolysis With
Recruiting
- Acute Distal Vessel Occlusion Stroke
- Alteplase (0.9mg/kg)
- Tenecteplase (0.25mg/kg)
-
Corbeil-Essonnes, FranceCentre Hospitalier Sud Francilien
Jan 2, 2023
Stroke, Ischemic Trial in ShenYang (Tenecteplase)
Not yet recruiting
- Stroke, Ischemic
- Tenecteplase
-
ShenYang, ChinaGeneral Hospital of Northern Theater Command
Dec 10, 2022
Stroke, Ischemic Trial in ShenYang (Tenecteplase)
Not yet recruiting
- Stroke, Ischemic
- Tenecteplase
-
ShenYang, ChinaGeneral Hospital of Northern Theater Command
Jan 4, 2023
Basilar Artery Occlusion, Thrombectomy, Tenecteplase Trial (Tenecteplase for Injection, Saline)
Not yet recruiting
- Basilar Artery Occlusion
- +2 more
- Tenecteplase for Injection
- Saline
- (no location specified)
Oct 12, 2022
Basilar Artery Occlusion, Acute Cerebrovascular Accident, Stroke Due to Basilar Artery Occlusion Trial (Tenecteplase, Aspiration
Not yet recruiting
- Basilar Artery Occlusion
- +2 more
- Tenecteplase
- +2 more
- (no location specified)
Jan 18, 2023
Tenecteplase REperfusion in Acute Ischemic sTroke
Recruiting
- Stroke, Ischemic
- rhTNK-tPA Thrombolysis
-
Beijing, ChinaYunyun Xiong
Feb 14, 2023
Stroke, Acute Trial in Paris
Not yet recruiting
- Stroke, Acute
-
Paris, FranceService des Urgences Cérébro-Vasculaires, Hôpitaux Universitaire
Sep 6, 2022
Ischemic Stroke Trial in Bern (Tenecteplase)
Not yet recruiting
- Ischemic Stroke
- Tenecteplase
-
Bern, SwitzerlandUniversitätsspital Bern
Aug 11, 2022
COVID-19, Respiratory Failure, ARDS Trial in New York (Tenecteplase, Placebo)
Completed
- COVID-19
- +2 more
- Tenecteplase
- Placebo
-
New York, New YorkMount Sinai Hospital
Jul 6, 2022
Acute Ischemic Stroke Trial in Barcelona (Tenecteplase)
Recruiting
- Acute Ischemic Stroke
- Tenecteplase
-
Barcelona, SpainHospital Universitari Vall d'Hebron
Nov 22, 2022
Ischemic Stroke, Acute, Cerebrovascular Disorders, Brain Disorder Trial in Australia (Intra-arterial tenecteplase injection at
Not yet recruiting
- Ischemic Stroke, Acute
- +3 more
- Intra-arterial tenecteplase injection at the completion of thrombectomy
- Placebo
-
Adelaide, Australia
- +11 more
May 26, 2023
Acute Ischemic Stroke, Intracranial Artery Occlusion, Endovascular Thrombectomy Trial in Hefei (Tenecteplase, endovascular
Not yet recruiting
- Acute Ischemic Stroke
- +2 more
- Tenecteplase
- endovascular thrombectomy alone
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of USTC, Division of Life Sciences
Jan 18, 2023
Stroke Trial in Shanghai (Tenecteplase, nonthrombolysis drug)
Recruiting
- Stroke
- Tenecteplase
- nonthrombolysis drug
-
Shanghai, Shanghai, ChinaHuashan Hospital
Jul 4, 2022
Ischemic Stroke Trial (intra-arterial tenecteplase)
Not yet recruiting
- Ischemic Stroke
- intra-arterial tenecteplase
- (no location specified)
Dec 28, 2021
Tirofiban Plus Intravenous Thrombolysis in Acute Anterior
Not yet recruiting
- Acute Anterior Choroidal Infarction (ACI)
- Paramedian Pontine Infarction (IPP)
- IVT with tenecteplase or alteplase
- Intervention Name : Tirofiban and IVT with tenecteplase or alteplase
-
Corbeil-Essonnes, FranceCentre Hospitalier Sud Francilien
Feb 17, 2023
Stroke Trial in Shanghai (Low dose tenecteplase, High dose tenecteplase)
Completed
- Stroke
- Low dose tenecteplase
- High dose tenecteplase
-
Shanghai, Shanghai, ChinaHuashan Hospital
Mar 30, 2022
Ischemic Stroke, Acute Trial (Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA), Best Medical
Not yet recruiting
- Ischemic Stroke, Acute
- Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
- Best Medical Management
- (no location specified)
Nov 24, 2022
Basilar Artery Occlusion Trial in Australia (Tenecteplase, Standard Care (which may include intravenous Alteplase))
Recruiting
- Basilar Artery Occlusion
- Tenecteplase
- Standard Care (which may include intravenous Alteplase)
-
Bankstown, New South Wales, Australia
- +10 more
May 29, 2022
(DIVA) in Medium-vessel-occlusion Strokes: a Retrospective Study
Not yet recruiting
- Acute Ischemic Stroke Due to Medium-vessel-occlusion
- alteplase
- Alteplase + possible complementary IVT with tenecteplase
-
Corbeil-Essonnes, FranceCentre Hospitalier Sud Francilien
Apr 13, 2023
Stroke, Acute, Stroke Ischemic Trial in Melbourne (Tenecteplase, Intravenous tissue plasminogen activator (tPA))
Completed
- Stroke, Acute, Stroke Ischemic
- Tenecteplase
- Intravenous tissue plasminogen activator (tPA)
-
Melbourne, Victoria, Australia
- +4 more
Dec 6, 2021
Stroke, Ischemic Trial in ShenYang (Tenecteplase)
Not yet recruiting
- Stroke, Ischemic
- Tenecteplase
-
ShenYang, ChinaGeneral Hospital of Northern Theater Command
Dec 10, 2022